BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2473112)

  • 21. The molecular basis of granuloma formation in schistosomiasis. II. Analogies of a T cell-derived suppressor effector factor to the T cell receptor.
    Perrin PJ; Prystowsky MB; Phillips SM
    J Immunol; 1989 Feb; 142(3):985-91. PubMed ID: 2464034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo treatment with monoclonal anti-I-A antibodies: disappearance of splenic antigen-presenting cell function concomitant with modulation of splenic cell surface I-A and I-E antigens.
    Kruisbeek AM; Titus JA; Stephany DA; Gause BL; Longo DL
    J Immunol; 1985 Jun; 134(6):3605-14. PubMed ID: 2580891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo staphylococcal enterotoxin B (SEB)-primed murine splenocytes secrete mediators which suppress CD25(hi) expression and cell cycle progression of naive splenocytes in response to SEB in vitro.
    Hsu LJ; Jan MS; Lin YS
    Cell Immunol; 2000 Apr; 201(1):50-7. PubMed ID: 10805973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Augmentation of antitumor immunity with bacterial superantigen, staphylococcal enterotoxin B-bound tumor cells.
    Shimizu M; Yamamoto A; Nakano H; Matsuzawa A
    Cancer Res; 1996 Aug; 56(16):3731-6. PubMed ID: 8706016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). V. T cell proliferative response and cellular interactions.
    Milich DR; Louie RE; Chisari FV
    J Immunol; 1985 Jun; 134(6):4194-202. PubMed ID: 3921619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A kinetic comparative study on lymphocyte responses to superantigen and phytohemagglutinin: reciprocal presentation of superantigen on the surface of activated lymphocytes.
    Ijichi S; Yamano Y; Osame M; Hall WW
    Cell Immunol; 1996 Nov; 173(2):312-6. PubMed ID: 8912892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.
    Pierres A; Naquet P; Van Agthoven A; Bekkhoucha F; Denizot F; Mishal Z; Schmitt-Verhulst AM; Pierres M
    J Immunol; 1984 Jun; 132(6):2775-82. PubMed ID: 6202760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clonal analysis of B and T cell responses to Ia antigens. III. Characterization of 12 xenogeneic anti-idiotypic antisera to A.TH-derived anti-I-Ak and anti-I-Ek monoclonal antibodies.
    Devaux C; Pierres M
    J Immunol; 1982 Feb; 128(2):751-7. PubMed ID: 6172506
    [No Abstract]   [Full Text] [Related]  

  • 29. Active suppression of host-vs-graft reaction in pregnant mice. VI. Soluble suppressor activity obtained from decidua of allopregnant mice blocks the response to IL 2.
    Clark DA; Chaput A; Walker C; Rosenthal KL
    J Immunol; 1985 Mar; 134(3):1659-64. PubMed ID: 3871455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies of T cell deletion and T cell anergy following in vivo administration of SEB to normal and lupus-prone mice.
    Scott DE; Kisch WJ; Steinberg AD
    J Immunol; 1993 Jan; 150(2):664-72. PubMed ID: 8419493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A single monoclonal anti-Ia antibody inhibits antigen-specific T cell proliferation controlled by distinct Ir genes mapping in different H-2 I subregions.
    Germain RN; Bhattacharya A; Dorf ME; Springer TA
    J Immunol; 1982 Mar; 128(3):1409-13. PubMed ID: 6173436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monoclonal anti-idiotypic antibodies to an I-J interacting molecule inhibit suppression in an H-2 restricted way.
    Jaureguiberry B; Liao L; Kuchroo V; Dorf ME; Diamond B
    J Immunol; 1988 May; 140(10):3286-9. PubMed ID: 2966194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T cell allotypic determinants encoded by genes linked to the immunoglobulin heavy chain locus. I. Establishment of monoclonal antibodies against allotypic determinants.
    Aihara Y; Tadokoro I; Katoh K; Minami M; Okuda K
    J Immunol; 1983 Jun; 130(6):2920-5. PubMed ID: 6406598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD95 (Fas)-based, superantigen-dependent, CD4+ T cell-mediated down-regulation of human in vitro immunoglobulin responses.
    Stohl W; Elliott JE; Lynch DH; Kiener PA
    J Immunol; 1998 Jun; 160(11):5231-8. PubMed ID: 9605118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Haplotype-specific suppression of antibody responses in vitro. III. Haplotype-specific suppressor factor (TsF-H) binds to but fails to suppress responses by the I-A mutant strain B6.C-H-2bm12.
    Sorensen CM; Pierce CW
    J Immunol; 1985 Dec; 135(6):4054-8. PubMed ID: 2415597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Active suppression of host-vs graft reaction in pregnant mice. IX. Soluble suppressor activity obtained from allopregnant mouse decidua that blocks the cytolytic effector response to IL-2 is related to transforming growth factor-beta.
    Clark DA; Falbo M; Rowley RB; Banwatt D; Stedronska-Clark J
    J Immunol; 1988 Dec; 141(11):3833-40. PubMed ID: 3263436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The immunobiology of the T cell response to Mls-locus-disparate stimulator cells. I. Unidirectionality, new strain combinations, and the role of Ia antigens.
    Janeway CA; Katz ME
    J Immunol; 1985 Apr; 134(4):2057-63. PubMed ID: 2579125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Requirements for suppressor cell activation. Role of accessory cells.
    Kuchroo VK; Minami M; Diamond B; Dorf ME
    J Immunol; 1989 Apr; 142(7):2192-9. PubMed ID: 2522479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential in vivo effects of a superantigen and an antibody targeted to the same T cell receptor. Activation-induced cell death vs passive macrophage-dependent deletion.
    Gonzalo JA; Baixeras E; González-García A; George-Chandy A; Van Rooijen N; Martínez C; Kroemer G
    J Immunol; 1994 Feb; 152(4):1597-608. PubMed ID: 8120373
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Superantigen-driven, CD8+ T cell-mediated down-regulation: CD95 (Fas)-dependent down-regulation of human Ig responses despite CD95-independent killing of activated B cells.
    Stohl W; Lynch DH; Starling GC; Kiener PA
    J Immunol; 1998 Oct; 161(7):3292-8. PubMed ID: 9759844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.